When Michael Gray was told he only had five months to live after being diagnosed with cancer, there was one faint hope that he could extend his life - a drug called cetuximab.
New treatment policy: When Michael Gray was told he only had five months to live after being diagnosed with cancer, there was one faint hope that he could extend his life � a drug called cetuximab.
When Michael Gray was told he only had five months to live after being diagnosed with cancer, there was one faint hope that he could extend his life - a drug called cetuximab.